デフォルト表紙
市場調査レポート
商品コード
1714250

動物用定位放射線手術システム市場- 世界の産業規模、シェア、動向、機会、予測、製品別、用途別、エンドユーザー別、地域別、競合別、2020-2030年

Veterinary Stereotactic Radiosurgery System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End User, By Region and Competition, 2020-2030F

出版日
ページ情報
英文 182 Pages
納期
2～3営業日
カスタマイズ可能
動物用定位放射線手術システム市場- 世界の産業規模、シェア、動向、機会、予測、製品別、用途別、エンドユーザー別、地域別、競合別、2020-2030年
出版日: 2025年04月25日
発行: TechSci Research
ページ情報: 英文 182 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

世界の動物用定位放射線手術システム市場は、2024年には34億6,000万米ドルと評価され、2030年には62億1,000万米ドルに成長すると予測され、CAGR10.22％を反映しています。

この成長の原動力は、コンパニオンアニマル、特に犬や猫の間でがんの有病率が増加し、ペットの飼い主が先進的で非侵襲的な治療ソリューションを求めるようになったことです。獣医定位放射線手術（SRS）は、健康な組織へのダメージを最小限に抑えながら、腫瘍をターゲットとした正確で高線量の放射線治療を提供します。SRSの採用が拡大している背景には、獣医腫瘍学の選択肢に対する意識の高まりと、動物特有のニーズに合わせた機器の継続的な技術革新があります。さらに、世界のペット飼育の増加とペットヘルスケア水準の向上により、高度な治療へのアクセスが拡大したことも市場を後押ししています。動物病院や専門病院が最先端技術を導入するにつれ、SRSシステムの需要は増加の一途をたどっています。さらに、獣医診断学と腫瘍学の進歩により、より正確で個別化された治療が可能になり、先進国と新興経済諸国の両方でこの市場セグメントの拡大に寄与しています。

市場概要
予測期間 2026-2030
市場規模：2024年 34億6,000万米ドル
市場規模：2030年 62億1,000万米ドル
CAGR：2025年～2030年 10.22%
急成長セグメント 脳腫瘍
最大市場 北米

市場促進要因

ペット飼育の増加

主な市場課題

獣医腫瘍専門医の不足

主な市場動向

非侵襲的治療への嗜好の高まり

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の動物用定位放射線手術システム市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 製品別（ガンマナイフ、リニアック、陽子線放射線治療（PBRT）/フラッシュRT、サイバーナイフ）
    • 用途別（脳腫瘍、脊髄腫瘍、その他の用途）
    • エンドユーザー別（動物病院、獣医専門クリニック、調査機関、学術機関）
    • 企業別（2024）
    • 地域別
  • 市場マップ

第6章 北米の動物用定位放射線手術システム市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州の動物用定位放射線手術システム市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域の動物用定位放射線手術システム市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米の動物用定位放射線手術システム市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの動物用定位放射線手術システム市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 合併と買収
  • 製品上市
  • 最近の動向

第13章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第14章 競合情勢

  • Avante Health Solutions
  • Accuray Inc.
  • Elekta AB
  • Varian Medical Systems Inc.
  • PetCure Oncology
  • Xstrahl Inc.
  • CVS Group
  • Medtronic PLC
  • Nanovi AS
  • Merck & Co. Inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

目次
Product Code: 28300

The Global Veterinary Stereotactic Radiosurgery System Market was valued at USD 3.46 billion in 2024 and is projected to grow to USD 6.21 billion by 2030, reflecting a compound annual growth rate (CAGR) of 10.22%. This growth is driven by the increasing prevalence of cancer among companion animals, especially dogs and cats, prompting pet owners to seek advanced and non-invasive treatment solutions. Veterinary stereotactic radiosurgery (SRS) offers precise, high-dose radiation therapy targeted at tumors while minimizing damage to healthy tissue. Its growing adoption is supported by rising awareness of veterinary oncology options, as well as continuous innovation in devices tailored for animal-specific needs. The market is further fueled by increasing global pet ownership and enhanced standards of pet healthcare, which have expanded access to sophisticated treatments. As veterinary clinics and specialty hospitals adopt more cutting-edge technologies, the demand for SRS systems continues to rise. Additionally, advancements in veterinary diagnostics and oncology are enabling more accurate, personalized care, contributing to the expansion of this market segment across both developed and emerging economies.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 3.46 Billion
Market Size 2030USD 6.21 Billion
CAGR 2025-203010.22%
Fastest Growing SegmentBrain Tumours
Largest MarketNorth America

Key Market Drivers

Growing Pet Ownership

The expansion of global pet ownership is a pivotal factor in the growth of the Veterinary Stereotactic Radiosurgery System market. With more households adopting pets, there is a corresponding increase in demand for high-quality veterinary healthcare. Particularly in developed regions, pets are increasingly regarded as family members, prompting owners to pursue advanced treatments such as SRS. This trend is also extending to emerging markets where improved access to veterinary services is enabling broader adoption of cutting-edge solutions. As the pet population grows and owners become more informed about specialized care, the demand for precise, non-invasive cancer treatment options like SRS is expected to continue climbing.

Key Market Challenges

Limited Availability of Specialized Veterinary Oncologists

A significant challenge to the broader adoption of veterinary SRS systems is the shortage of trained veterinary oncologists capable of operating the complex equipment and designing effective treatment plans. The precision required for SRS treatment necessitates both technical and clinical expertise, which remains limited in many regions. Additionally, the cost and availability of training programs for veterinary professionals in oncology are insufficient to meet rising demand. These limitations, particularly in rural or underserved areas, hinder the deployment and effective utilization of SRS systems, slowing the market's overall penetration.

Key Market Trends

Increasing Preference for Non-Invasive Treatments

There is a marked shift toward non-invasive treatment methods in veterinary medicine, driven by heightened concern for animal welfare and the desire for improved recovery outcomes. Stereotactic radiosurgery offers an effective, pain-minimizing alternative to traditional surgery, particularly for treating brain and spinal tumors. With faster recovery times, reduced risk of complications, and minimal hospitalization, SRS is becoming increasingly preferred by pet owners and veterinarians alike. As non-invasive methods become more mainstream in both human and animal healthcare, the veterinary field is embracing technologies that enhance treatment precision and pet comfort.

Key Market Players

  • Avante Health Solutions
  • Accuray Inc.
  • Elekta AB
  • Varian Medical Systems Inc.
  • PetCure Oncology
  • Xstrahl Inc.
  • CVS Group
  • Medtronic PLC
  • Nanovi AS
  • Merck & Co. Inc.

Report Scope:

In this report, the Global Veterinary Stereotactic Radiosurgery System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Stereotactic Radiosurgery System Market, By Product:

  • Gamma Knife
  • LINAC
  • Proton Beam Radiation Therapy (PBRT)/ Flash-RT
  • CyberKnife

Veterinary Stereotactic Radiosurgery System Market, By Application:

  • Brain Tumours
  • Spinal Tumours
  • Other Applications

Veterinary Stereotactic Radiosurgery System Market, By End User:

  • Veterinary Hospitals
  • Veterinary Specialty Clinics
  • Research and Academic Institutions

Veterinary Stereotactic Radiosurgery System Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Stereotactic Radiosurgery System Market.

Available Customizations:

Global Veterinary Stereotactic Radiosurgery System Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Veterinary Stereotactic Radiosurgery System Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Gamma Knife, LINAC, Proton Beam Radiation Therapy (PBRT)/ Flash-RT, CyberKnife)
    • 5.2.2. By Application (Brain Tumours, Spinal Tumours, Other Applications)
    • 5.2.3. By End User (Veterinary Hospitals, Veterinary Specialty Clinics, Research and Academic Institutions)
    • 5.2.4. By Company (2024)
    • 5.2.5. By Region
  • 5.3. Market Map

6. North America Veterinary Stereotactic Radiosurgery System Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Veterinary Stereotactic Radiosurgery System Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Mexico Veterinary Stereotactic Radiosurgery System Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Canada Veterinary Stereotactic Radiosurgery System Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Veterinary Stereotactic Radiosurgery System Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Veterinary Stereotactic Radiosurgery System Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Veterinary Stereotactic Radiosurgery System Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Veterinary Stereotactic Radiosurgery System Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Veterinary Stereotactic Radiosurgery System Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Veterinary Stereotactic Radiosurgery System Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Veterinary Stereotactic Radiosurgery System Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Veterinary Stereotactic Radiosurgery System Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Veterinary Stereotactic Radiosurgery System Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. South Korea Veterinary Stereotactic Radiosurgery System Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. Japan Veterinary Stereotactic Radiosurgery System Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Veterinary Stereotactic Radiosurgery System Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Veterinary Stereotactic Radiosurgery System Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Veterinary Stereotactic Radiosurgery System Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Veterinary Stereotactic Radiosurgery System Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Veterinary Stereotactic Radiosurgery System Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Veterinary Stereotactic Radiosurgery System Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Veterinary Stereotactic Radiosurgery System Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Veterinary Stereotactic Radiosurgery System Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Veterinary Stereotactic Radiosurgery System Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Avante Health Solutions
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Accuray Inc.
  • 14.3. Elekta AB
  • 14.4. Varian Medical Systems Inc.
  • 14.5. PetCure Oncology
  • 14.6. Xstrahl Inc.
  • 14.7. CVS Group
  • 14.8. Medtronic PLC
  • 14.9. Nanovi AS
  • 14.10. Merck & Co. Inc.

15. Strategic Recommendations

16. About Us & Disclaimer